BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2021
View Archived Issues
Aberrant NAD+ metabolism underlies Zika microcephaly
Read More
Phase II study initiated to assess aspacytarabine in AML and MDS patients
Read More
Moderna initiates phase I/II study of mRNA-3705 for methylmalonic acidemia
Read More
Chengdu Biobel patents compounds for C. difficile infection
Read More
Chinese researchers divulge new PD-1/PD-L1 interaction inhibitors
Read More
Jasan Bio Medicine (Jiaxing) synthesizes new DHFR inhibitors
Read More
Clinical trial finds PRAX-114 improves symptoms of perimenopausal depression
Read More
AgeX Therapeutics describes new exosomes for wound healing
Read More
Neurodevelopmental disorders tied to genetic variation in CLCN3 gene
Read More
Inhibitors of TNF-alpha- and IL-6-induced adhesion show activity in IBD models
Read More
BBP-631 enters phase I/II for treating congenital adrenal hyperplasia
Read More
Initiation of phase II trial to assess TLX-66 for pediatric leukemia
Read More
Phase II study cleared to evaluate TQ Formula in COVID-19 patients
Read More
TRIDENT-2 study evaluates repotrectinib combined with trametinib in KRAS G12D mutant solid tumors
Read More
IND application accepted for phase I/Ib trial for CPI-818 for treating R/R T-cell lymphoma in China
Read More
Crovalimab evaluated for vaso-occlusive episodes in patients with sickle cell disease
Read More
Green light for censavudine to initiate phase II trial in neurodegeneration
Read More
Transient nanofibrillar hydrogels release glucagon under low-glucose conditions
Read More